English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduFor this study, the researchers examined placental tissue, which shares many developmental and physiological similarities with the lung and the immune response of the small and large intestine, making it a key source of human tissue that can be used for ongoing COVID-19 research. It also contains a unique expression pattern of COVID-19 receptors that are different from other organs, which could be helpful in the development of COVID-19 treatments.
“The results of this study provide evidence for ongoing research of COVID-19 infection at the maternal-fetal interface as means to better understand virus transmission and infection in other human tissues,” said Elisha Wachman, MD, a neonatologist at Boston Medical Center, associate professor of pediatrics at Boston University School of Medicine, and principal investigator of this study. “Previous research has shown that the placenta protects the fetus from various types of infection, and exploring the particular ways in which it protects the fetus from COVID-19 transmission may help identify new targets of COVID-19 prevention and treatment.”
Throughout April and May 2020, samples from 15 COVID-19 positive maternal-fetal dyads were collected for this study; five cases had evidence of fetal transmission. The placental tissue of the positive cases was analyzed and compared with ten COVID-19 negative controls. The researchers found that the COVID-19 virus was present in the placental tissues in cases with and without evidence of fetal infection. They also found that the placenta contains a unique pattern of cell surface proteins (TMPRSS2 and ACE2) that are important for COVID-19 viral entry, which is different from other cell types. The demographics of mother-baby dyads were also studied and no differences were found to be significant, showing the fetal transmission does not discriminate.
“Determining how the placenta could be preventing COVID-19 infections during pregnancy can help provide clues on how to prevent infection in other organs, such as the lungs and gut,” said Elizabeth Taglauer, MD, PhD, a neonatologist and placental biologist based at Boston Children’s Hospital. “As a readily available tissue for research, the placenta can be a valuable source of scientific study for a variety of human diseases in pregnancy and beyond.”
###
Funding for this study was provided by the Boston University Clinical and Translational Science Institute COVID-19 Pilot Grant Program (UL1TR001430), NIH T32 1T32HD098061-01 (EST) and the Boston University School of Medicine Medical Student Summer Research Program.
About Boston Medical Center
Boston Medical Center is a private, not-for-profit, 514-bed, academic medical center that is the primary teaching affiliate of Boston University School of Medicine. It is the largest and busiest provider of trauma and emergency services in New England. Boston Medical Center offers specialized care for complex health problems and is a leading research institution, receiving more than $97 million in sponsored research funding in fiscal year 2018. It is the 15th largest funding recipient in the U.S. from the National Institutes of Health among independent hospitals. In 1997, BMC founded Boston Medical Center Health Plan, Inc., now one of the top ranked Medicaid MCOs in the country, as a non-profit managed care organization. Boston Medical Center and Boston University School of Medicine are partners in Boston HealthNet – 14 community health centers focused on providing exceptional health care to residents of Boston. For more information, please visit http://www.
